tiprankstipranks
Ambu A/S Class B (AMBFF)
:AMBFF
Holding AMBFF?
Track your performance easily

Ambu (AMBFF) Stock Price & Analysis

35 Followers

AMBFF Stock Chart & Stats


Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

20.28%<0.01%76.35%
Insiders
<0.01% Other Institutional Investors
76.35% Public Companies and
Individual Investors

AMBFF FAQ

What was Ambu A/S Class B’s price range in the past 12 months?
Ambu A/S Class B lowest stock price was $14.70 and its highest was $23.80 in the past 12 months.
    What is Ambu A/S Class B’s market cap?
    Ambu A/S Class B’s market cap is $5.05B.
      When is Ambu A/S Class B’s upcoming earnings report date?
      Ambu A/S Class B’s upcoming earnings report date is Jan 30, 2025 which is yesterday.
        How were Ambu A/S Class B’s earnings last quarter?
        Ambu A/S Class B released its earnings results on Nov 04, 2024. The company reported -$0.071 earnings per share for the quarter, missing the consensus estimate of $0.072 by -$0.143.
          Is Ambu A/S Class B overvalued?
          According to Wall Street analysts Ambu A/S Class B’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Ambu A/S Class B pay dividends?
            Ambu A/S Class B pays a Notavailable dividend of $0.052 which represents an annual dividend yield of 0.29%. See more information on Ambu A/S Class B dividends here
              What is Ambu A/S Class B’s EPS estimate?
              Ambu A/S Class B’s EPS estimate is 0.1.
                How many shares outstanding does Ambu A/S Class B have?
                Ambu A/S Class B has 234,974,400 shares outstanding.
                  What happened to Ambu A/S Class B’s price movement after its last earnings report?
                  Ambu A/S Class B reported an EPS of -$0.071 in its last earnings report, missing expectations of $0.072. Following the earnings report the stock price went same 0%.
                    Which hedge fund is a major shareholder of Ambu A/S Class B?
                    Currently, no hedge funds are holding shares in AMBFF
                    ---

                    Company Description

                    Ambu A/S Class B

                    Ambu A/S engages in the development, production, and marketing of diagnostic and life-supporting devices for hospitals and rescue services. It operates through the following segments: Anaesthesia; Patient Monitoring & Diagnostics; and Visualisation. The Anaesthesia segment offers products from resuscitators, face masks, and laryngeal masks to the single use flexible intubation scope. The Patient Monitoring & Diagnostics segmet provides electrodes for cardiology, neurophysiology, and polysomnography. The Visualisation segment includes single-use visualisation devices, which are used in single lung ventilation procedure, or a bedside bronchoscopy procedure in the intensive care unit . The company was founded by Holger Hesse in 1937 and is headquartered in Ballerup, Denmark.
                    ---

                    AMBFF Company Deck

                    ---

                    AMBFF Earnings Call

                    Q4 2024
                    0:00 / 0:00
                    Earnings Call Sentiment|Neutral
                    The earnings call presented strong growth in revenue and strategic advancements, particularly in the Endoscopy segment. However, challenges in the GI segment and potential contract losses in Anaesthesia & Patient Monitoring were noted.Read More>
                    ---
                    Similar Stocks
                    Company
                    Price & Change
                    Follow
                    Teleflex
                    Conmed
                    Merit Medical Systems
                    Insulet
                    Atricure
                    Inogen
                    Popular Stocks
                    ---
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis